LUNG NEUROENDOCRINE NEOPLASM
Clinical trials for LUNG NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new LUNG NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for LUNG NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost lung cancer survival
Disease control OngoingThis study tests whether adding an immunotherapy drug (nivolumab) to precise, high-dose radiation (SABR) helps keep early-stage non-small cell lung cancer from coming back. About 140 people with stage I-IIA or recurrent lung cancer will be randomly assigned to get radiation alone…
Matched conditions: LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
New pill shows promise for slowing rare cancers
Disease control OngoingThis study tests an experimental drug called CVM-1118 in 34 people with advanced neuroendocrine tumors that have not responded to standard treatments. The goal is to see if the drug can slow tumor growth or shrink tumors. Participants take the drug by mouth, and their progress is…
Matched conditions: LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: TaiRx, Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Massive study aims to uncover best treatments for rare tumors
Knowledge-focused OngoingThis study follows over 2,500 people with neuroendocrine tumors (NETs) to learn how symptoms and treatments affect their quality of life. Participants fill out surveys about their well-being and care experiences for up to 18 months. The goal is to find which treatments work best …
Matched conditions: LUNG NEUROENDOCRINE NEOPLASM
Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated May 08, 2026 12:01 UTC